We demonstrate that sGC co-expression gene modules can be successfully used to stratify patient kidney samples by DKD renal outcome measures such as GFR, albuminuria, glomerulosclerosis, and interstitial fibrosis, indicating the relevance of the sGC pathway to patients. Here, SGCB is linked to diabetic kidney disease.